Gold nanoparticle trafficking of typically excluded compounds across the cell membrane in JB6 Cl 41-5a cells causes assay interference

Analytical methods to assess nanoparticle toxicity

(2009) Bryce J. Marquis et al.   ANALYST

Development ofin vitrosystems for nanotoxicology: methodological considerations

(2009) Vicki Stone et al.   CRITICAL REVIEWS IN TOXICOLOGY

Evaluation of nanoparticle immunotoxicity

(2009) Marina A. Dobrovolskaia et al.   Nature Nanotechnology

Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles

(2009) Wan-Seob Cho et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Current in vitro methods in nanoparticle risk assessment: Limitations and challenges

(2008) Alexandra Kroll et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution

(2008) Marina A. Dobrovolskaia et al.   MOLECULAR PHARMACEUTICS

Method for Analysis of Nanoparticle Hemolytic Properties in Vitro

(2008) Marina A. Dobrovolskaia et al.   NANO LETTERS

Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line

(2008) N.A. Monteiro-Riviere et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY